C.M. Bidwell & Associates’s Compugen CGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$763 Hold
358
﹤0.01% 441
2025
Q4
$548 Hold
358
﹤0.01% 467
2025
Q3
$526 Hold
358
﹤0.01% 471
2025
Q2
$637 Hold
358
﹤0.01% 402
2025
Q1
$523 Hold
358
﹤0.01% 417
2024
Q4
$548 Hold
358
﹤0.01% 452
2024
Q3
$648 Hold
358
﹤0.01% 454
2024
Q2
$601 Hold
358
﹤0.01% 432
2024
Q1
$924 Hold
358
﹤0.01% 424
2023
Q4
$709 Hold
358
﹤0.01% 439
2023
Q3
$333 Hold
358
﹤0.01% 514
2023
Q2
$408 Hold
358
﹤0.01% 500
2023
Q1
$251 Hold
358
﹤0.01% 506
2022
Q4
$256 Buy
+358
New +$312 ﹤0.01% 485
2022
Q3
Sell
-358
Closed -$1K 483
2022
Q2
$1K Hold
358
﹤0.01% 452
2022
Q1
$1K Buy
+358
New +$1.21K ﹤0.01% 489

Other funds holding CGEN

C.M. Bidwell & Associates's CGEN Position: Q1 2026 in Review

C.M. Bidwell & Associates held its Compugen (CGEN) position steady in Q1 2026 at 358 shares worth $763. The position accounts for ﹤0.01% of the portfolio, ranked #441.

C.M. Bidwell & Associates first reported a position in CGEN in Q1 2022 and has held it in 16 quarters since. The position peaked at $1K in Q2 2022. 78 funds tracked by Wall St. Rank hold CGEN as of Q1 2026.

  • C.M. Bidwell & Associates held 358 shares of Compugen worth $763 as of Q1 2026.
  • C.M. Bidwell & Associates left its Compugen share count unchanged in Q1 2026.
  • Compugen made up ﹤0.01% of C.M. Bidwell & Associates's portfolio in Q1 2026, its #441 holding.
  • C.M. Bidwell & Associates first reported a position in Compugen in Q1 2022 and has held it in 16 quarters since.
  • C.M. Bidwell & Associates's Compugen position peaked at $1K in Q2 2022.
  • 78 funds tracked by Wall St. Rank held Compugen as of Q1 2026.

Based on C.M. Bidwell & Associates's 13F filing for Q1 2026, filed 15 May 2026.